Literature DB >> 15187092

The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.

Carmen R Tchen1, Matthew Brook, Jeremy Saklatvala, Andrew R Clark.   

Abstract

Tristetraprolin (TTP) is an mRNA-destabilizing protein that negatively regulates the expression of proinflammatory mediators such as tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor, and cyclooxygenase 2. Here we investigate the regulation of TTP expression in the mouse macrophage cell line RAW264.7. We show that TTP mRNA is expressed in a biphasic manner following stimulation of cells with lipopolysaccharide and that the second phase of expression, like the first, is dependent on mitogen-activated protein kinase (MAPK) p38. MAPK p38 acts through a downstream kinase to stabilize TTP mRNA, and this stabilization is mediated by an adenosine/uridine-rich region at the 3'-end of the TTP 3'-untranslated region. Hence TTP is post-transcriptionally regulated in a similar manner to several proinflammatory genes. We also demonstrate that TTP is able to bind to its own 3'-untranslated region and negatively regulate its own expression, forming a feedback loop to limit expression levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187092     DOI: 10.1074/jbc.M402059200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

Review 1.  The roles of TTP and BRF proteins in regulated mRNA decay.

Authors:  Sandhya Sanduja; Fernando F Blanco; Dan A Dixon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 Jan-Feb       Impact factor: 9.957

2.  A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control.

Authors:  Edward Hitti; Suhad Al-Yahya; Maher Al-Saif; Peer Mohideen; Linah Mahmoud; Stephen J Polyak; Khalid S A Khabar
Journal:  RNA       Date:  2010-04-23       Impact factor: 4.942

Review 3.  Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression.

Authors:  Shivendra Kishore; Sandra Luber; Mihaela Zavolan
Journal:  Brief Funct Genomics       Date:  2010-12-01       Impact factor: 4.241

4.  Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.

Authors:  Sandra L Clement; Claudia Scheckel; Georg Stoecklin; Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

5.  Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs.

Authors:  Rudolf Pullmann; Hyeon Ho Kim; Kotb Abdelmohsen; Ashish Lal; Jennifer L Martindale; Xiaoling Yang; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2007-07-09       Impact factor: 4.272

6.  Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes.

Authors:  G-Y Gwak; J-H Yoon; S-H Lee; S-M Lee; H-S Lee; G J Gores
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-29       Impact factor: 4.553

7.  Control of mRNA stability by SAPKs.

Authors:  Miguel A Rodríguez-Gabriel; Paul Russell
Journal:  Top Curr Genet       Date:  2008-01-01

8.  LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP.

Authors:  Thomas Hochdörfer; Christopher Tiedje; Deborah J Stumpo; Perry J Blackshear; Matthias Gaestel; Michael Huber
Journal:  Cell Signal       Date:  2013-03-14       Impact factor: 4.315

Review 9.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18

10.  Negative feedback regulation of the yeast CTH1 and CTH2 mRNA binding proteins is required for adaptation to iron deficiency and iron supplementation.

Authors:  Mar Martínez-Pastor; Sandra V Vergara; Sergi Puig; Dennis J Thiele
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.